Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.
Xeris Biopharma reported substantial year-over-year revenue growth for its Cushing’s syndrome treatment Recorlev in Q2 2026, driven by increased patient demand and strategic commercial investments. The company also secured a Notice of Allowance for a new Keveyis patent, potentially extending intellectual property prot…
Cosmos Health Inc., through its subsidiary Cana Laboratories, has progressed its international patent application WO2025108566A1 for a novel hydrogel designed to aid body weight management. The company has entered the national and regional patent phases in the United States, Europe, Australia, and Canada, consolidatin…
CanVeer Biopharma Inc. has filed an international Patent Cooperation Treaty (PCT) application for its lead investigational drug candidate AlveoShield™, marking a strategic step in securing global intellectual property rights. The filing supports CanVeer’s development of disease-modifying therapies for severe respirato…
Second medical use claims face a complex legal landscape in Southeast Asia. Thailand has issued clear guidelines endorsing patent protection for new medical indications, whereas Indonesia pragmatically applies European Patent Convention principles to allow 'product for use' claims despite legislative ambiguities. Conv…
The African Regional Intellectual Property Organization (ARIPO) and the African Intellectual Property Organization (OAPI) provide centralized patent filing systems covering over half of Sub-Saharan Africa’s population. This article examines their procedural frameworks, economic contexts, and practical advantages for i…
Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.